LENZ Therapeutics (LENZ) Profit After Tax (QoQ) (2020 - 2026)
LENZ Therapeutics (LENZ) Profit After Tax (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn |
| 10 | LENZ Therapeutics | 178.71 Mn | -79.67 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.73% |
| Dec 31, 2025 | -117.13% |
| Sep 30, 2025 | -10.72% |
| Jun 30, 2025 | -2.00% |
| Mar 31, 2025 | -11.01% |
| Dec 31, 2024 | -36.75% |
| Sep 30, 2024 | 6.09% |
| Jun 30, 2024 | 38.41% |
| Mar 31, 2024 | 29.72% |
| Dec 31, 2023 | -25.46% |
| Sep 30, 2023 | -28.21% |
| Jun 30, 2023 | -16.23% |
| Mar 31, 2023 | 47.32% |
| Dec 31, 2022 | 4.73% |
| Sep 30, 2022 | 2.66% |
| Jun 30, 2022 | -0.39% |
| Mar 31, 2022 | -36.48% |
| Dec 31, 2021 | -29.73% |
| Sep 30, 2021 | 16.76% |
| Jun 30, 2021 | 11.06% |